Cargando…
The Benefits and Risks of New Therapies for Type 2 Diabetes
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438152/ https://www.ncbi.nlm.nih.gov/pubmed/18774876 http://dx.doi.org/10.18553/jmcp.2008.14.7.655 |
| _version_ | 1785092725225291776 |
|---|---|
| author | Asche, Car V. Nelson, Richard E. |
| author_facet | Asche, Car V. Nelson, Richard E. |
| author_sort | Asche, Car V. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10438152 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2008 |
| publisher | Academy of Managed Care Pharmacy |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104381522023-08-21 The Benefits and Risks of New Therapies for Type 2 Diabetes Asche, Car V. Nelson, Richard E. J Manag Care Pharm Commentary Academy of Managed Care Pharmacy 2008-09 /pmc/articles/PMC10438152/ /pubmed/18774876 http://dx.doi.org/10.18553/jmcp.2008.14.7.655 Text en Copyright © 2008, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
| spellingShingle | Commentary Asche, Car V. Nelson, Richard E. The Benefits and Risks of New Therapies for Type 2 Diabetes |
| title | The Benefits and Risks of New Therapies for Type 2 Diabetes |
| title_full | The Benefits and Risks of New Therapies for Type 2 Diabetes |
| title_fullStr | The Benefits and Risks of New Therapies for Type 2 Diabetes |
| title_full_unstemmed | The Benefits and Risks of New Therapies for Type 2 Diabetes |
| title_short | The Benefits and Risks of New Therapies for Type 2 Diabetes |
| title_sort | benefits and risks of new therapies for type 2 diabetes |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438152/ https://www.ncbi.nlm.nih.gov/pubmed/18774876 http://dx.doi.org/10.18553/jmcp.2008.14.7.655 |
| work_keys_str_mv | AT aschecarv thebenefitsandrisksofnewtherapiesfortype2diabetes AT nelsonricharde thebenefitsandrisksofnewtherapiesfortype2diabetes AT aschecarv benefitsandrisksofnewtherapiesfortype2diabetes AT nelsonricharde benefitsandrisksofnewtherapiesfortype2diabetes |